Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder

NCT07213466 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Bipolar I Disorder
Bipolar II Disorder
Schizo Affective Disorder
Obesity
Weight Loss
GLP - 1

Interventions

BEHAVIORAL: Group Therapy Program
DRUG: semaglutide
DRUG: Phentermine-Topiramate
DRUG: naltrexone and bupropion (combination)

Sponsor

Mayo Clinic

Collaborators

[object Object]